[1]
Witkowska, M., Witkowska, S., Klimczak, M., Frydecka, A., Witkowski, M. and Smolewski, P. 2021. Quality of life patients treated with rituximab intravenous versus subcutaneous in B-cell lymphomas: results from outpatient Hematooncology Clinic in Lodz. OncoReview. 11, 2(42) (Jul. 2021), 33-39. DOI:https://doi.org/10.24292/01.OR.1222550621.